Cambridge Investment Research Advisors, Inc.
Position in JNJ — Johnson & Johnson
CIK 1419186
FAIRFIELD, IA
Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$123,591,960
+$6,878,460 QoQ
Shares Held
486,640
+1.9% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#270
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $708,681,337 across 15 Drug Manufacturers - General names. JNJ ranks #3 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
181,813 | $218,071,984 | |
| 2 | ABBV |
AbbVie Inc.
|
566,381 | $142,524,114 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
486,640 | $123,591,960 | |
| 4 | MRK |
Merck & Co., Inc.
|
469,217 | $60,294,384 | |
| 5 | PFE |
Pfizer Inc
|
1,820,575 | $43,839,446 | |
| 6 | AMGN |
Amgen Inc
|
107,825 | $39,045,589 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
434,411 | $25,030,761 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
144,124 | $18,208,626 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,591,960 | 486,640 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $116,713,500 | 477,473 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $97,553,539 | 471,387 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $87,235,474 | 470,475 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $69,979,204 | 458,129 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $79,385,452 | 478,687 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $63,503,075 | 439,103 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $74,633,329 | 460,529 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $66,705,523 | 456,387 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $78,628,655 | 497,052 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $75,684,103 | 482,864 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $79,819,383 | 512,484 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $93,680,016 | 565,974 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $86,102,965 | 555,503 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $92,449,600 | 523,349 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $83,630,028 | 511,937 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $89,215,993 | 502,597 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $86,797,329 | 489,744 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $83,189,972 | 486,292 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $77,732,049 | 481,313 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $85,441,906 | 518,647 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $86,015,859 | 523,370 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $78,102,972 | 496,270 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $77,520,624 | 520,692 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $70,722,686 | 502,899 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $64,280,843 | 490,207 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||